Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain
Compared to SMBG, rt-CGM is highly likely to be a cost-effective intervention for patients living with insulin-treated T2D in Spain.
Authors
- Hamza Alshannaq (ORCID: https://orcid.org/0000-0003-3952-1113)
- Sabrina Ilham
- Gregory J. Norman (ORCID: https://orcid.org/0000-0001-7989-9597)
- Richard Fulton Pollock (ORCID: https://orcid.org/0000-0002-9873-7507)
- Juan Francisco Merino-Torres (ORCID: https://orcid.org/0000-0002-0191-4504)
- Waqas Ahmed (ORCID: https://orcid.org/0000-0002-9035-7614)
Institutions
- Universitat de València (ES)
- Dexcom (United States) (US)
- A-T Society (GB)
- Covalence Research
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/ceor.s483459
- Citations
- 4
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Dexcom